Our first idea today, an instrument maker, beat analysts’ estimates by $0.30 last quarter. The Street is forecasting annual growth of 23.45% for the company over the next five years.
Buy: MKS Instruments, Inc. (MKSI)
From Cabot Undervalued Stocks Advisor
MKS Instruments is a 60-year-old global provider of instruments, subsystems and process control solutions that measure, monitor, deliver, analyze, power and control critical parameters of advanced manufacturing processes to improve process performance and productivity for their customers. The company’s primary served markets include the semiconductor, industrial technologies, life and health sciences, research, and defense.
MKS offers the largest breadth of products and services in its market, with 2200 patents and a sales presence in 100 countries. Investors can tune in to webcasts as the CFO and CEO speak at industry conferences on May 26, May 27, and June 8.
MKSI is an undervalued, small-cap growth stock, a good choice for growth investors and traders. Analysts’ consensus estimates point toward EPS growth of 12% and 38% in 2020 and 2021. If MKSI rises past the top of its trading range near 108, there’s additional price resistance at 120. Strong Buy.
Crista Huff, Cabot Undervalued Stocks Advisor, cabotwealth.com, 978-745-5532, May 27, 2020